Detalhe da pesquisa
1.
Phase II Study of Bendamustine and Ofatumumab in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma Who Are Poor Candidates for R-CHOP Chemotherapy.
Oncologist
; 24(8): 1035-e623, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31073022
2.
Erlotinib plus either pazopanib or placebo in patients with previously treated advanced non-small cell lung cancer: A randomized, placebo-controlled phase 2 trial with correlated serum proteomic signatures.
Cancer
; 124(11): 2355-2364, 2018 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29645086
3.
Neoadjuvant Durvalumab Alone or Combined with Novel Immuno-Oncology Agents in Resectable Lung Cancer: The Phase II NeoCOAST Platform Trial.
Cancer Discov
; 13(11): 2394-2411, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37707791
4.
A Phase II Study Evaluating Orteronel, an Inhibitor of Androgen Biosynthesis, in Patients With Androgen Receptor (AR)-Expressing Metastatic Breast Cancer (MBC).
Clin Breast Cancer
; 22(3): 269-278, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34824002
5.
Clinical Outcomes for Plasma-Based Comprehensive Genomic Profiling Versus Standard-of-Care Tissue Testing in Advanced Non-Small Cell Lung Cancer.
Clin Lung Cancer
; 23(1): 72-81, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34782240
6.
Combined lenvatinib and pembrolizumab as salvage therapy in advanced adrenal cortical carcinoma.
J Immunother Cancer
; 8(2)2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32737143
7.
Continuous Versus 1-Year Fixed-Duration Nivolumab in Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 153.
J Clin Oncol
; 38(33): 3863-3873, 2020 11 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-32910710
8.
Clinical Utility of Comprehensive Cell-free DNA Analysis to Identify Genomic Biomarkers in Patients with Newly Diagnosed Metastatic Non-small Cell Lung Cancer.
Clin Cancer Res
; 25(15): 4691-4700, 2019 Aug 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30988079
9.
Safety, Efficacy, and Patient-Reported Health-Related Quality of Life and Symptom Burden with Nivolumab in Patients with Advanced Non-Small Cell Lung Cancer, Including Patients Aged 70 Years or Older or with Poor Performance Status (CheckMate 153).
J Thorac Oncol
; 14(9): 1628-1639, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31121324
10.
Amrubicin and carboplatin with pegfilgrastim in patients with extensive stage small cell lung cancer: A phase II trial of the Sarah Cannon Oncology Research Consortium.
Lung Cancer
; 117: 38-43, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29496254
11.
Economic evaluation of weekly epoetin alfa versus biweekly darbepoetin alfa for chemotherapy-induced anaemia: evidence from a 16-week randomised trial.
Pharmacoeconomics
; 24(5): 479-94, 2006.
Artigo
em Inglês
| MEDLINE | ID: mdl-16706573
12.
Shifting guidelines for myeloid growth factors: applications in cancer chemotherapy.
Curr Hematol Rep
; 4(6): 441-5, 2005 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-16232380
13.
Early hemoglobin response and alternative metrics of efficacy with erythropoietic agents for chemotherapy-related anemia.
Curr Med Res Opin
; 21(10): 1527-33, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16238892
14.
Randomized phase II trial of Onartuzumab in combination with erlotinib in patients with advanced non-small-cell lung cancer.
J Clin Oncol
; 31(32): 4105-14, 2013 Nov 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-24101053
15.
Randomized, double-blind, placebo-controlled, phase II trial of sorafenib and erlotinib or erlotinib alone in previously treated advanced non-small-cell lung cancer.
J Clin Oncol
; 29(18): 2582-9, 2011 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-21576636